July 21, 2021
The US Food and Drug Administration (FDA) has approved odevixibat (Bylvay, Albireo Pharma), the first treatment for pruritus associated with all types of progressive familial intrahepatic […]
July 19, 2021
Patients with infected pancreatic necrosis (IPN) are more likely to experience organ failure and mortality, which makes identifying them as quickly as possible especially crucial. A […]
July 19, 2021
Patients with hepatocellular carcinoma (HCC) can be offered transarterial radioembolization (TARE) as a safe and effective first-line treatment or adjunct to other locoregional therapies, authors of […]
July 12, 2021
The American Gastroenterological Association recently published a clinical practice update concerning endoscopic evaluation and management of early complications after bariatric/metabolic surgery. The seven best practice advice […]
July 9, 2021
Moderate fibrosis in patients with alcoholic liver disease is not a benign condition, say investigators who studied the natural history of ALD according to biopsy-proven fibrosis […]
July 9, 2021
Moderate fibrosis in patients with alcoholic liver disease is not a benign condition, say investigators who studied the natural history of ALD according to biopsy-proven fibrosis […]
July 9, 2021
Stopping nucleoside analog therapy in patients with hepatitis B viral (HBV) infections results in sustained viral suppression in only a minority of patients, but a new […]
July 6, 2021
NEW YORK (Reuters Health) – Obese patients who choose sleeve gastrectomy (SG) may have fewer complications requiring emergency care and hospitalization than peers who choose Roux-en-Y […]
July 6, 2021
NEW YORK (Reuters Health) – Adalimumab is effective and well tolerated in children with moderate-to-severe ulcerative colitis (UC), with “clinically meaningful” rates of clinical remission and […]